SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (431)5/3/1998 6:31:00 PM
From: Buendia  Read Replies (1) | Respond to of 2135
 
I don't think I am alone in rushing to the net with that incredible front page NYTimes article. It may be old news to the regulars on this thread, but not to thousands of "outsiders." I predict a pop of 1 - 2 points on Monday, and as word gets out about ENMD's spin off to J&J and rumored licensing of endostatin to BMY later in the month (per the Yahoo thread), the stock will start a two to three day run that will make a lot of people happy...IMHO

Bd



To: StockDoc who wrote (431)5/3/1998 8:47:00 PM
From: LTK007  Read Replies (2) | Respond to of 2135
 
" This article is going to help shorters " Stock Doc,how can you
expect this article to help shorters?Do you mean,that because the stock will run up wildly,and then the shorters will come and wait for
the pullback--that is the only way I can understand this statement.
I repeat I am not a shareholder in ENMD,nor will become one tomorrow-my fascination is with Folkman and his quest,nothing more--
max90


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News